Baird Financial Group’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $1.66M | Sell |
5,380
-4,705
| -47% | -$1.46M | ﹤0.01% | 1142 |
|
|
2026
Q2 | $2.82M | Buy |
10,085
+5,966
| +145% | +$1.57M | ﹤0.01% | 970 |
|
|
2026
Q1 | $1.1M | Sell |
4,119
-78
| -2% | -$21.1K | ﹤0.01% | 1238 |
|
|
2025
Q4 | $1.05M | Sell |
4,197
-13,246
| -76% | -$3.52M | ﹤0.01% | 1233 |
|
|
2025
Q3 | $5.01M | Buy |
17,443
+8,795
| +102% | +$2.36M | 0.01% | 736 |
|
|
2025
Q2 | $2.27M | Buy |
8,648
+4,892
| +130% | +$1.19M | ﹤0.01% | 977 |
|
|
2025
Q1 | $874K | Sell |
3,756
-29
| -0.8% | -$7.04K | ﹤0.01% | 1220 |
|
|
2024
Q4 | $868K | Sell |
3,785
-452
| -11% | -$104K | ﹤0.01% | 1218 |
|
|
2024
Q3 | $947K | Sell |
4,237
-5,353
| -56% | -$1.18M | ﹤0.01% | 1191 |
|
|
2024
Q2 | $1.95M | Sell |
9,590
-29,772
| -76% | -$6.06M | ﹤0.01% | 966 |
|
|
2024
Q1 | $8.6M | Sell |
39,362
-32,763
| -45% | -$7.22M | 0.02% | 514 |
|
|
2023
Q4 | $16.4M | Sell |
72,125
-2,463
| -3% | -$517K | 0.04% | 353 |
|
|
2023
Q3 | $15M | Sell |
74,588
-2,488
| -3% | -$525K | 0.04% | 350 |
|
|
2023
Q2 | $18.6M | Buy |
77,076
+64,277
| +502% | +$14.5M | 0.05% | 315 |
|
|
2023
Q1 | $2.94M | Buy |
12,799
+233
| +2% | +$55.8K | 0.01% | 768 |
|
|
2022
Q4 | $2.96M | Sell |
12,566
-7,618
| -38% | -$1.73M | 0.01% | 743 |
|
|
2022
Q3 | $4.13M | Sell |
20,184
-772
| -4% | -$184K | 0.01% | 618 |
|
|
2022
Q2 | $4.91M | Buy |
20,956
+1,499
| +8% | +$372K | 0.01% | 582 |
|
|
2022
Q1 | $5.13M | Sell |
19,457
-169,911
| -90% | -$46.5M | 0.01% | 607 |
|
|
2021
Q4 | $59.5M | Sell |
189,368
-1,855
| -1% | -$535K | 0.14% | 174 |
|
|
2021
Q3 | $53.8M | Buy |
191,223
+2,548
| +1% | +$747K | 0.14% | 180 |
|
|
2021
Q2 | $52M | Buy |
188,675
+2,028
| +1% | +$538K | 0.14% | 180 |
|
|
2021
Q1 | $47.6M | Buy |
186,647
+2,968
| +2% | +$693K | 0.13% | 183 |
|
|
2020
Q4 | $37.4M | Buy |
183,679
+73,628
| +67% | +$14.8M | 0.11% | 211 |
|
|
2020
Q3 | $20.7M | Buy |
110,051
+52,022
| +90% | +$9.6M | 0.07% | 262 |
|
|
2020
Q2 | $9.6M | Buy |
58,029
+41,361
| +248% | +$6.66M | 0.04% | 352 |
|
|
2020
Q1 | $2.11M | Buy |
16,668
+3,056
| +22% | +$513K | 0.01% | 672 |
|
|
2019
Q4 | $2.3M | Sell |
13,612
-28,947
| -68% | -$4.86M | 0.01% | 729 |
|
|
2019
Q3 | $7.15M | Buy |
42,559
+2,821
| +7% | +$479K | 0.03% | 424 |
|
|
2019
Q2 | $6.87M | Hold |
39,738
| – | – | 0.03% | 434 |
|
|
2019
Q1 | $2.42M | Buy |
15,822
+1,322
| +9% | +$190K | 0.01% | 607 |
|
|
2018
Q4 | $1.83M | Sell |
14,500
-1,077
| -7% | -$168K | 0.01% | 660 |
|
|
2018
Q3 | $2.7M | Buy |
15,577
+612
| +4% | +$108K | 0.02% | 592 |
|
|
2018
Q2 | $2.69M | Buy |
14,965
+87
| +0.6% | +$15.3K | 0.02% | 586 |
|
|
2018
Q1 | $2.41M | Sell |
14,878
-3,004
| -17% | -$514K | 0.02% | 593 |
|
|
2017
Q4 | $2.85M | Sell |
17,882
-2,958
| -14% | -$455K | 0.02% | 537 |
|
|
2017
Q3 | $3.15M | Sell |
20,840
-1,793
| -8% | -$278K | 0.02% | 511 |
|
|
2017
Q2 | $3.49M | Sell |
22,633
-10,464
| -32% | -$1.49M | 0.03% | 478 |
|
|
2017
Q1 | $4.75M | Sell |
33,097
-168,256
| -84% | -$23.2M | 0.04% | 407 |
|
|
2016
Q4 | $25.8M | Sell |
201,353
-177,686
| -47% | -$23M | 0.22% | 136 |
|
|
2016
Q3 | $52.1M | Sell |
379,039
-2,941
| -0.8% | -$403K | 0.47% | 46 |
|
|
2016
Q2 | $49.8M | Buy |
381,980
+39,884
| +12% | +$5M | 0.46% | 50 |
|
|
2016
Q1 | $40.1M | Sell |
342,096
-7,424
| -2% | -$829K | 0.38% | 69 |
|
|
2015
Q4 | $43.2M | Buy |
349,520
+31,098
| +10% | +$3.73M | 0.43% | 56 |
|
|
2015
Q3 | $34.5M | Sell |
318,422
-5,643
| -2% | -$679K | 0.37% | 77 |
|
|
2015
Q2 | $39.3M | Hold |
324,065
| – | – | 0.39% | 79 |
|
Other funds holding LH
Baird Financial Group's LH Position: Q3 2026 in Review
Baird Financial Group reduced its Labcorp (LH) stake by 47% in Q3 2026, selling an estimated $1.46M and leaving 5,380 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1142.
Baird Financial Group first reported a position in LH in Q2 2015 and has held it in 46 quarters since. The position peaked at $59.5M in Q4 2021. 1,095 funds tracked by Wall St. Rank hold LH as of Q3 2026.
- Baird Financial Group held 5,380 shares of Labcorp worth $1.66M as of Q3 2026.
- Baird Financial Group sold 4,705 Labcorp shares in Q3 2026, an estimated $1.46M.
- Labcorp made up ﹤0.01% of Baird Financial Group's portfolio in Q3 2026, its #1142 holding.
- Baird Financial Group first reported a position in Labcorp in Q2 2015 and has held it in 46 quarters since.
- Baird Financial Group's Labcorp position peaked at $59.5M in Q4 2021.
- 1,095 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.
Based on Baird Financial Group's 13F filing for Q3 2026, filed 13 Nov 2026.